NCT03170960 2025-08-17Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid TumorsExelixisPhase 1 Active not recruiting914 enrolled
NCT03367741 2025-07-28Cabozantinib S-malate and Nivolumab in Treating Patients With Advanced, Recurrent, or Metastatic Endometrial CancerNational Cancer Institute (NCI)Phase 2 Active not recruiting82 enrolled